Atherosclerosis and cardiovascular disease in systemic lupus erythematosus: effects of in vivo statin treatment

Inflammation and immune system interactions in atherosclerosis

(2013) Bart Legein et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Mitochondrial dysfunction in antiphospholipid syndrome: implications in the pathogenesis of the disease and effects of coenzyme Q10 treatment

(2012) C. Perez-Sanchez et al.   BLOOD

Association between Serum Total Antioxidant Status and Coronary Microvascular Functions in Patients with SLE

(2012) Sema Yılmaz et al.   ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES

Monocytes as a diagnostic marker of cardiovascular diseases

(2012) Alexei Gratchev et al.   IMMUNOBIOLOGY

Increased neutrophil oxidative burst metabolism in systemic lupus erythematosus

(2012) SF Perazzio et al.   LUPUS

Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure

(2012) Takafumi Oka et al.   NATURE

Accelerated atherosclerosis in patients with SLE—mechanisms and management

(2012) Brian J. Skaggs et al.   Nature Reviews Rheumatology

Effects of NFKB1 and NFKBIA Gene Polymorphisms on Susceptibility to Environmental Factors and the Clinicopathologic Development of Oral Cancer

(2012) Chiao-Wen Lin et al.   PLoS One

Translating the effects of statins: From redox regulation to suppression of vascular wall inflammation

(2012) A. S. Antonopoulos et al.   THROMBOSIS AND HAEMOSTASIS

Macrophages and neutrophils in SLE—An online molecular catalog

(2011) Jacob Orme et al.   AUTOIMMUNITY REVIEWS

Netting Neutrophils Induce Endothelial Damage, Infiltrate Tissues, and Expose Immunostimulatory Molecules in Systemic Lupus Erythematosus

(2011) E. Villanueva et al.   JOURNAL OF IMMUNOLOGY

SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex

(2011) Fuminori Tokunaga et al.   NATURE

Neutrophils in the pathogenesis and manifestations of SLE

(2011) Mariana J. Kaplan   Nature Reviews Rheumatology

Anti-phospholipid antibodies contribute to arteriosclerosis in patients with systemic lupus erythematosus through induction of tissue factor expression and cytokine production from peripheral blood mononuclear cells

(2011) Yukari Motoki et al.   THROMBOSIS RESEARCH

Effects of rosuvastatin on vascular biomarkers and carotid atherosclerosis in lupus: A randomized, double-blind, placebo-controlled trial

(2011) Chi Chiu Mok et al.   ARTHRITIS CARE & RESEARCH

Lupus Atherosclerosis Prevention Study (LAPS)

(2010) M. A. Petri et al.   ANNALS OF THE RHEUMATIC DISEASES

Global effects of fluvastatin on the prothrombotic status of patients with antiphospholipid syndrome

(2010) C. Lopez-Pedrera et al.   ANNALS OF THE RHEUMATIC DISEASES

Differential expression of protease-activated receptors in monocytes from patients with primary antiphospholipid syndrome

(2010) Chary López-Pedrera et al.   ARTHRITIS AND RHEUMATISM

The Transcription Factor ETS-1 Mediates Proinflammatory Responses and Neointima Formation in Carotid Artery Endoluminal Vascular Injury

(2010) Wenguang Feng et al.   HYPERTENSION

Accelerated Atherosclerosis in Systemic Lupus Erythematosus: Role of Proinflammatory Cytokines and Therapeutic Approaches

(2010) Chary López-Pedrera et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Atherosclerosis in thrombotic primary antiphospholipid syndrome

(2009) P. R. J. AMES et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus

(2009) Louise E Full et al.   ARTHRITIS RESEARCH & THERAPY

Antibodies to oxidized LDL/β2-glycoprotein I in antiphospholipid syndrome patients with venous and arterial thromboembolism

(2008) V. Pengo et al.   THROMBOSIS RESEARCH